Trials / Not Yet Recruiting
Not Yet RecruitingNCT07106372
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
A Multi-center, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Stapokibatrt in Children With Atopic Dermatitis
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Keymed Biosciences Co.Ltd · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, single-arm, open-label phase 3 study to evaluate the safety, efficacy, Pharmacokinetics(PK) and immunogenicity of Stapokibatrt in children with Atopic Dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stapokibatrt | Stapokibatrt Subcutaneous injection |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2027-02-01
- Completion
- 2027-06-01
- First posted
- 2025-08-06
- Last updated
- 2025-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07106372. Inclusion in this directory is not an endorsement.